Childhood and Adolescent Depression: Clinical Review and Treatment Guidelines

A clinical review paper from Creighton University authored by Shashi Kant Bhatia, sourced from the paperswithcode platform. It discusses major depression affecting 3 to 5 percent of children and adolescents, covering diagnostic criteria, risk factors, and evidence-based treatment options. The dataset likely contains the full text of this medical literature.

Use Cases

• Extract biomedical risk factors based on mentions of family history, sex, abuse, and chronic illness.
• Identify treatment recommendations based on the discussion of cognitive behavior therapy and antidepressants like fluoxetine.
• Analyze diagnostic criteria and symptom expression variations described for different developmental stages.
• Study safety protocols and monitoring schedules based on the described black box warnings and patient follow-up plans.

Strengths

• Provides specific prevalence statistics (3 to 5 percent) for childhood and adolescent depression.
• Cites concrete treatment guidelines, including FDA-approved use of fluoxetine for ages 8 to 17.
• Details specific monitoring protocols (e.g., weekly for the first month) for treatment-emergent suicidality.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Creighton University, author Shashi Kant Bhatia

Collection Method

Likely a published clinical review paper aggregated by paperswithcode.